Formoterol Fumarate
Showing 1 - 25 of 970
COPD Trial in Worldwide (Treatment A : Budesonide, Glycopyrronium, and Formoterol Fumarate, Treatment B: Budesonide and
Not yet recruiting
- Chronic Obstructive Pulmonary Disease
- Treatment A : Budesonide, Glycopyrronium, and Formoterol Fumarate
- +2 more
-
Torrance, California
- +25 more
Sep 28, 2023
Type 2 Diabetes, Obesity Trial in Sherbrooke (drug, other, diagnostic test, procedure)
Recruiting
- Type 2 Diabetes
- Obesity
- Formoterol Fumarate 12 micrograms Inhalation Powder
- +8 more
-
Sherbrooke, Quebec, CanadaCentre de recherche du CHUS
Sep 22, 2022
COPD Trial in Glendale (Treatment A: BGF MDI HFO, Treatment B: BGF MDI HFA)
Recruiting
- Chronic Obstructive Pulmonary Disease
- Treatment A: BGF MDI HFO
- Treatment B: BGF MDI HFA
-
Glendale, CaliforniaResearch Site
Jan 18, 2023
Asthma Trial in Medford (Budesonide 80 µg and Formoterol Fumarate Dihydrate 4.5 µg, Symbicort, 80 Mcg-4.5 Mcg/Inh Inhalation
Recruiting
- Asthma
- Budesonide 80 μg and Formoterol Fumarate Dihydrate 4.5 μg
- +2 more
-
Medford, OregonVelocity Clinical Research
May 6, 2022
COPD (COPD) Trial in Guelph (BGF MDI HFO 320/14.4/9.6µg, BGF MDI HFA 320/14.4/9.6 µg, Placebo MDI HFA)
Not yet recruiting
- COPD (Chronic Obstructive Pulmonary Disease)
- BGF MDI HFO 320/14.4/9.6μg
- +2 more
-
Guelph, Ontario, CanadaResearch Site
Oct 4, 2023
Asthma Trial (Mometasone Furoate/Formoterol Fumarate (MF/F) 100/5 mcg MDI, Mometasone Furoate/Formoterol Fumarate (MF/F) 200/5
Completed
- Asthma
- Mometasone Furoate/Formoterol Fumarate (MF/F) 100/5 mcg MDI
- Mometasone Furoate/Formoterol Fumarate (MF/F) 200/5 mcg MDI
- (no location specified)
Feb 7, 2022
Asthma Trial in Rotterdam (Budesonide/Formoterol fumarate dihydrate)
Recruiting
- Asthma
- Budesonide/Formoterol fumarate dihydrate
-
Rotterdam, Zuid-Holland, NetherlandsFranciscus Gasthuis & Vlietland
Apr 14, 2023
Asthma Trial (Mometasone Furoate/Formoterol Fumarate Combination MDI 100/10 mcg BID, Mometasone Furoate MDI (MF MDI), Formoterol
Completed
- Asthma
- Mometasone Furoate/Formoterol Fumarate Combination MDI 100/10 mcg BID
- +3 more
- (no location specified)
Feb 7, 2022
Asthma Trial (mometasone furoate/formoterol fumarate combination MDI 200/10 mcg BID, Mometasone furoate MDI (MF MDI) 200 mcg,
Completed
- Asthma
- mometasone furoate/formoterol fumarate combination MDI 200/10 mcg BID
- +3 more
- (no location specified)
Feb 7, 2022
COPD Trial in Brooklyn (Treatment A (BGF MDI HFO with oral activated charcoal), Treatment B (BGF MDI HFA with oral activated
Recruiting
- Chronic Obstructive Pulmonary Disease
- Treatment A (BGF MDI HFO with oral activated charcoal)
- Treatment B (BGF MDI HFA with oral activated charcoal)
-
Brooklyn, MarylandResearch Site
Aug 11, 2022
Pulmonary Disease, Chronic Obstructive Trial in London (CHF1535, Formoterol fumarate)
Completed
- Pulmonary Disease, Chronic Obstructive
- CHF1535
- Formoterol fumarate
-
London, United KingdomUCL Medical School
Oct 28, 2021
Asthma Trial in Edegem (Test product (T):CHF 5993 BDP/FF/GB 200/6/12.5 µg pMDI, Reference product 1 (R1): CHF 5993 BDP/FF/GB
Recruiting
- Asthma
- Test product (T):CHF 5993 BDP/FF/GB 200/6/12.5 µg pMDI
- +2 more
-
Edegem, Antwerpen, BelgiumSGS Belgium NV - Clinical Pharmacology Unit
Jun 1, 2023
Symptom and Quality of Life in COPD by
Recruiting
- Pulmonary Disease, Chronic Obstructive
-
Nagoya, Aichi, Japan
- +16 more
Jan 17, 2023
Asthma, Airway Inflammation Trial (mometasone furoate/formoterol 100/10 mcg, mometasone furoate/formoterol 200/10 mcg,
Completed
- Asthma
- Airway Inflammation
- mometasone furoate/formoterol 100/10 mcg
- +5 more
- (no location specified)
Feb 7, 2022
Asthma, COPD (COPD) Trial in Baltimore (CHF5993, CHF5259, Moxifloxacin 400mg)
Recruiting
- Asthma
- Chronic Obstructive Pulmonary Disease (COPD)
- CHF5993
- +3 more
-
Baltimore, MarylandPAREXEL Baltimore Early Phase Clinical Unit
Apr 13, 2023
COPD Trial in Berlin-Spandau (CHF5993, CHF1535, Matched )
Recruiting
- Chronic Obstructive Pulmonary Disease
- CHF5993
- +2 more
-
Berlin-Spandau, Berlin Spandauer Damm, GermanyPAREXEL International GmbH Early Phase Clinical Unit Berlin
Jan 21, 2022
Asthmatic Trial in Manchester (NEXThaler 100/6 mcg DPI, Flixotide Accuhaler 500 mcg, NEXThaler 200/6 mcg DPI)
Completed
- Asthmatic
- NEXThaler 100/6 mcg DPI
- +3 more
-
Manchester, United KingdomThe Medicine Evaluation Unit
Oct 28, 2021
Asthma, COPD Trial (SCH No. 418131 (Mometasone Furoate/Formoterol Furoate abbreviated MF/F ))
Completed
- Asthma
- COPD
- SCH No. 418131 (Mometasone Furoate/Formoterol Furoate abbreviated MF/F )
- (no location specified)
Feb 7, 2022
Asthma Trial in Nyíregyháza (Administration via pressurized metered dose inhaler (pMDI))
Recruiting
- Asthma
- Administration via pressurized metered dose inhaler (pMDI)
-
Nyíregyháza, HungarySimplex Kft
Mar 14, 2022
Real-world, 52-week Prospective Study to Capture Reasons for
Not yet recruiting
- Pulmonary Disease, Chronic Obstructive (COPD)
- Budesonide Glycopyrronium bromide Formoterol fumarate pressurized Metered Dose Inhaler
- (no location specified)
Jun 13, 2023
COPD Trial in Godollo (BDP/FF/GB, FlF/VI + Tiotropium)
Completed
- Chronic Obstructive Pulmonary Disease
- BDP/FF/GB
- FlF/VI + Tiotropium
-
Godollo, HungaryErzsebet Gondozohaz
Oct 28, 2021
Asthma Trial (Mometasone furoate/formoterol (MF/F) MDI, Fluticasone propionate/salmeterol (F/SC) DPI)
Completed
- Asthma
- Mometasone furoate/formoterol (MF/F) MDI
- Fluticasone propionate/salmeterol (F/SC) DPI
- (no location specified)
Feb 7, 2022
Real-life After Initation of Treatment With Trixeo
Not yet recruiting
- Chronic Obstructive Pulmonary Disease
- BGF (budesonide/glycopyrrolate/formoterol fumarate)
-
Acquaviva delle Fonti, Italy
- +23 more
May 8, 2023
Asthma Trial (Beclomethasone Dipropionate/Formoterol Fumarate, Beclomethasone Dipropionate)
Not yet recruiting
- Asthma
- Beclomethasone Dipropionate/Formoterol Fumarate
- Beclomethasone Dipropionate
- (no location specified)
Mar 14, 2022